Eli Lilly & Co. (LLY) Says FDA Granted Priority Review For Potential New Indication For Its Verzenio As Initial Treatment Of Advanced Breast Cancer

CAMBRIDGE, Mass.—Eli Lilly & Co., one of the biggest makers of insulin, has been planning a risky new business venture: making the high-tech devices that deliver insulin to diabetes patients.

In a research laboratory Lilly opened here in 2015, scientists have been developing a wearable, automated insulin-delivery device designed to reduce the decision-making and guesswork of conventional insulin injections. They are also developing a “smart pen” injection device that can wirelessly transmit dosing information to a patient’s...

Source : https://www.wsj.com/articles/eli-lilly-bets-big-on-insulin-delivery-devices-1511269200

Eli Lilly Bets Big on Insulin-Delivery Devices
DexCom teams up with Lilly to combine CGM into insulin lineup
Dexcom Announces Development Agreement with Lilly to Integrate Dexcom CGM into Connected Diabetes Ecosystem
Eli Lilly tripled the price of insulin under Trump's pick for HHS and Democrats are pouncing on that
Eli Lilly and Company: #WeWontRest until we speed up innovation to patients
HHS nominee Azar made millions working for drugmaker Lilly
CrownBio’s Translatable FATZO Model Utilized in Eli Lilly’s Preclinical Type 2 Diabetes Research Programs
DexCom (DXCM) Reports Development Agreement with Eli Lily (LLY) for Dexcom CGM Integration Into Connected Diabetes Ecosystem
Health Nominee Alex Azar Reaped Big Earnings During Lilly Tenure
[LIMITED STOCK!] Related eBay Products